Author | Richard Kim, MD, | OncLive

Author | Richard Kim, MD,

Articles

Dr. Kim on the Safety Profile of Atezolizumab/Bevacizumab in HCC

September 14, 2020

Richard D. Kim, MD, discusses the safety profile of the combination of atezolizumab and bevacizumab in hepatocellular carcinoma.

Dr. Kim on the Evolving Treatment Landscape of Advanced HCC

August 14, 2020

Richard D. Kim, MD, discusses the evolving treatment landscape of advanced hepatocellular carcinoma.

Dr. Kim on Efficacy and Next Steps With Regorafenib/Nivolumab Combo in CRC

July 03, 2020

Richard D. Kim, MD, discusses the efficacy of and next steps for a phase 1/1b study with regorafenib and nivolumab in patients with mismatch repair proficient advanced refractory colorectal cancer.

Dr. Kim on Immunotherapy in CRC

December 18, 2019

Richard Kim, MD, discusses the use of immunotherapy in colorectal cancer.

x